Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta

Mamo, Maria; Wirth, Francesca; Azzopardi, Lilian M.; Serracino‐Inglott, Anthony

doi:10.1136/ejhpharm-2013-000351

Cited by 6 publications

(4 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…By setting forth a process of care focused on comprehensive medication management, ACCP articulates a practice that clinical pharmacists and their colleagues in other health professions can use as a basis for optimizing collaborative patient care. This is consistent with efforts currently under way to develop a standardized approach to collaborative clinical pharmacist practice in Europe . The Standards also delineates the components essential to the clinical pharmacist's documentation of the care process and patients’ medication‐related outcomes.…”

supporting

confidence: 61%

Standards of Practice for Clinical Pharmacists: The Time Has Come

Yee

Haas

2014

Pharmacotherapy

View full text Add to dashboard Cite

(Pharmacotherapy 2014;34(8):769–770) doi: 10.1002/phar.1450 The lack of a standardized and reproducible practice by which clinical pharmacists optimize patients ’ medication-related outcomes has been an Achilles ’ heel for the clinical pharmacy disci-pline. Without a well-defined patient care process that is used by clinical pharmacists consistently and collaboratively across practice settings, other members of the health care team have remained uncertain, and perhaps even doubtful, of what to expect from clinical pharmacists and whether clinical pharmacists could reliably contribute to improved patient outcomes. Researchers seeking to study the impact of clinical pharmacists on patient outcomes have been hampered by the hig

show abstract

supporting

confidence: 61%

Standards of Practice for Clinical Pharmacists: The Time Has Come

Yee

Haas

2014

Pharmacotherapy

View full text Add to dashboard Cite

show abstract

“…38 Apart from enabling the pharmacist to be fully informed about patient-specific issues, documentation of information and interventions enables pharmacist accountability and continuity of care as well as demonstration of the value of clinical pharmacy service provision to high-quality care and improvement of patient outcomes. [39][40][41][42] The strengths of the study include the development and implementation of a Gap-Finding Tool which is versatile and can be used in any ward or ambulatory clinical setting to update provision of service and compare national or regional practices to international standards. The Gap-Finding Tool could be used to identify gaps and subsequently provide a pharmaceutical service aimed at closing the gaps.…”

Section: Discussionmentioning

confidence: 99%

Development and use of an innovative Gap Finding Tool to create a Pharmaceutical Care Model within a paediatric oncology setting

Falzon

Galea

Calvagna

et al. 2021

J Oncol Pharm Pract

Self Cite

View full text Add to dashboard Cite

Introduction A paediatric cancer ward is a setting where pharmacists participate in direct patient care, acting as coordinators between the patient, caregivers and healthcare professionals. The aim of the study was to develop a Gap Finding Tool to support the setting up of a pharmaceutical care model at a Paediatric-Adolescent Cancer Ward. Methods The Standards of Practice for Clinical Pharmacy Services by the Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Clinical Pharmacy (2013), the American College of Clinical Pharmacy (2014) and the European Association of Hospital Pharmacists (2014) were used to compile the Gap Finding Tool. The developed Tool was tested for content validity by a panel of experts and subsequently implemented over 2 months. Results The Gap Finding Tool comprised of nine sections with an average of eight statements each about pharmacy services that should be provided at ward level. For each statement, the rater indicates whether these contributions are provided. When the Tool was implemented at the Paediatric-Adolescent Cancer Ward, four major gaps were identified, namely, absence of a clinical pharmacist, lack of medicines information, vetting of chemotherapy prescriptions by pharmacist with limited access to patient data and lack of pharmacist-input on medicines availability. Processes requiring optimisation included discharge medication advice and documentation processes. Conclusion The developed Gap Finding Tool is an innovative tool which is versatile and can be used in ward or ambulatory clinical settings to identify gaps in pharmaceutical processes and services and compare national or regional practices to international standards.

show abstract

“…The pharmacy patient profile of each patient was reviewed to determine whether care issues generated by MAT application resulted in a documented intervention by the clinical pharmacist. The pharmaceutical care issues were classified in terms of a set of care issue types defined in the hospital standard operating procedure for patient profiling 19…”

Section: Methodsmentioning

confidence: 99%

Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons

Gauci

Wirth

Azzopardi

et al. 2019

Pharm Pract (Granada)

Self Cite

View full text Add to dashboard Cite

Background: Optimisation of drug therapy is important in the older population and may be facilitated by medication assessment tools (MATs). Objective: The purpose of the study was to evaluate whether appropriateness of drug therapy and clinical pharmacist intervention documentation improved following implementation of a previously developed MAT for the long-term management of atrial fibrillation (MAT-AF). Methods: Adherence to MAT-AF review criteria and clinical pharmacist intervention documentation was assessed by the researcher pre-MAT implementation in 150 patients aged ≥60 years admitted to a rehabilitation hospital with a diagnosis of atrial fibrillation. MAT-AF was introduced as a clinical tool in the hospital for identification of pharmaceutical care issues in atrial fibrillation patients. Adherence to MAT-AF and pharmacist intervention documentation were assessed by the researcher post-MAT implementation for a further 150 patients with the same inclusion criteria. Logistic regression analysis and measurement of odds ratio was used to identify differences in adherence to MAT-AF pre- and post-MAT implementation. The differences between two population proportions z-test was used to compare pharmacist intervention documentation pre- and post-MAT implementation. Results: Adherence to MAT-AF criteria increased from 70.9% pre-implementation to 89.6% post-implementation. MAT-AF implementation resulted in a significant improvement in prescription of anticoagulant therapy (OR 4.07, p<0.001) and monitoring of laboratory parameters for digoxin (OR 10.40, p<0.001). Clinical pharmacist intervention documentation improved significantly post-implementation of MAT-AF (z-score 20.249, p<0.001). Conclusions: Implementation of MAT-AF within an interdisciplinary health care team significantly improved the appropriateness of drug therapy and pharmacist intervention documentation in older patients with atrial fibrillation.

show abstract

Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta

Cited by 6 publications

References 23 publications

Standards of Practice for Clinical Pharmacists: The Time Has Come

Standards of Practice for Clinical Pharmacists: The Time Has Come

Development and use of an innovative Gap Finding Tool to create a Pharmaceutical Care Model within a paediatric oncology setting

Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons

Contact Info

Product

Resources

About